Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis.

Trallero-Araguás E, Rodrigo-Pendás JÁ, Selva-O'Callaghan A, Martínez-Gómez X, Bosch X, Labrador-Horrillo M, Grau-Junyent JM, Vilardell-Tarrés M.

Arthritis Rheum. 2012 Feb;64(2):523-32. doi: 10.1002/art.33379. Review.

2.

A novel autoantibody to a 155-kd protein is associated with dermatomyositis.

Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group.

Arthritis Rheum. 2006 Nov;54(11):3682-9.

3.
4.

Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays.

Labrador-Horrillo M, Martínez MA, Selva-O'Callaghan A, Trallero-Araguás E, Balada E, Vilardell-Tarrés M, Juarez C.

Ann Rheum Dis. 2012 Jun;71(6):993-6. doi: 10.1136/annrheumdis-2011-200871. Epub 2012 Jan 30.

PMID:
22294626
5.

Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy.

Trallero-Araguás E, Labrador-Horrillo M, Selva-O'Callaghan A, Martínez MA, Martínez-Gómez X, Palou E, Rodriguez-Sanchez JL, Vilardell-Tarrés M.

Medicine (Baltimore). 2010 Jan;89(1):47-52. doi: 10.1097/MD.0b013e3181ca14ff.

6.

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.

Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ; Juvenile Dermatomyositis Research Group UK.

Rheumatology (Oxford). 2008 Mar;47(3):324-8. doi: 10.1093/rheumatology/kem359. Epub 2008 Jan 30.

PMID:
18238791
7.

[Diagnostic value of anti-alpha-fodrin antibody testing for Sjögren's syndrome: a meta-analysis].

Huang QS, LE AP, Luo ZQ, Li JM, Wang WQ, Ju BH, Wan LG.

Zhonghua Yi Xue Za Zhi. 2008 Nov 18;88(42):2971-6. Chinese.

PMID:
19080074
8.

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.

Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG.

Ann Rheum Dis. 2007 Oct;66(10):1345-9. Epub 2007 Mar 28.

9.

Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.

Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL.

Medicine (Baltimore). 2014 Nov;93(24):318-32. doi: 10.1097/MD.0000000000000222. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

10.

Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis.

Tampoia M, Giavarina D, Di Giorgio C, Bizzaro N.

Autoimmun Rev. 2012 Dec;12(2):121-6. doi: 10.1016/j.autrev.2012.07.006. Epub 2012 Jul 7. Review.

PMID:
22781589
11.

Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis.

Zou M, Tang L, Zhao S, Zhao Z, Chen L, Chen P, Huang Z, Li J, Chen L, Fan X.

PLoS One. 2012;7(8):e43347. doi: 10.1371/journal.pone.0043347. Epub 2012 Aug 14. Review.

12.

Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.

Petri MH, Satoh M, Martin-Marquez BT, Vargas-Ramírez R, Jara LJ, Saavedra MA, Cruz-Gonzalez C, Andrade-Ortega L, Vera-Lastra O, Salazar-Páramo M, Prieto-Parra RE, Gonzalez-Lopez L, Gamez-Nava JI, Ramírez-Sánchez HU, Chan JY, Ross SJ, Chan EK, Vázquez-Del Mercado M.

Arthritis Res Ther. 2013 Apr 4;15(2):R48. doi: 10.1186/ar4207.

13.
14.

A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.

Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD.

J Am Acad Dermatol. 2006 Apr;54(4):597-613. Epub 2006 Jan 23. Review.

PMID:
16546580
15.
16.

Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.

Muro Y, Ishikawa A, Sugiura K, Akiyama M.

Rheumatology (Oxford). 2012 Aug;51(8):1508-13. doi: 10.1093/rheumatology/kes073. Epub 2012 Apr 25.

PMID:
22539482
17.

Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review.

Virgili G, Menchini F, Dimastrogiovanni AF, Rapizzi E, Menchini U, Bandello F, Chiodini RG.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4963-73. Review.

PMID:
17962446
18.

Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis.

Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K.

CMAJ. 2008 Mar 25;178(7):855-62. doi: 10.1503/cmaj.071124. Review.

19.

Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.

Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS; Tests in Prediction of Pre-eclampsia Severity review group.

BJOG. 2006 Apr;113(4):369-78. Review.

20.

Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis.

Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F.

Int J Obes (Lond). 2010 May;34(5):791-9. doi: 10.1038/ijo.2010.5. Epub 2010 Feb 2. Review.

PMID:
20125098

Supplemental Content

Support Center